We are happy to announce that we are re-opening Phase 1 of the Fight AIDS@Home project. In collaboration with World Community Grid, and thanks to their affiliated volunteers around the globe, High Throughput Virtual Screening will be performed by targeting the HIV-1 capsid protein with the goal of discovering new chemical compounds to defeat the AIDS virus (HIV). Read more in this update.
During the maturation of the HIV virus, the HIV-1 capsid protein (CA) assembles with thousands of copies to forms the capsid core [ref 1] with a characteristic conical shape (see Figure 1C). This core encloses the RNA viral genome. Upon the entry of the HIV in host cells, the capsid core is released into the cytoplasm, and it dissociates in connection with the reverse transcription in a not completely understood process. This leads to the importation of DNA viral genome in the host cell’s nucleus, where it is integrated in the host DNA to finalize the infection.
The critical role of CA protein, in early and late stages of the viral replication life cycle, has led to recent efforts on drug development, targeting the mature form of the protein. Currently, none of these molecules are used in clinic, and some face natural polymorphism and resistant mutations [ref 2]. Therefore, continued development of drugs targeting the CA protein is still needed
Different level of the capsid protein structure
CA protein consist of a sequence of 231 amino acids which folds into 3 different domains: The N-terminal domain (N-ter), the linker, and the C-terminal domain (C-ter). This protein chain complexes with other chains to form hexamers or pentamers; which assemble together to form the fullerene-cone shape of the capsid core. There are several models of the core assembly, but all are composed of ~200 hexamers, and exactly 12 pentamers.
High Throughput Virtual Screening
The FightAIDS@Home team is working with World Community Grid to find active compounds which could attach to the CA proteins and mediate the assembly of the capsid core. This computational experiment will be performed using the docking software AutoDock VINA [ref 3].
Thanks to the volunteers, around 2 million molecules will be screened across ~50 conformations of the capsid protein, and hopefully lead to a reduced selection of molecules. This will be the starting point of a drug discovery process targeting the HIV-1 capsid protein.
With the support of our collaborators from the HIV Interaction and Viral Evolution (HIVE), experimental biding assays and infectivity assays will be conducted to determine if the selected compounds could be optimized as a promising drug candidate.
Four pockets of interest
Based on X-ray structures of CA protein, models of the core, and computational analysis of their flexibility, four pockets of interest have been selected on the surface of the hexamer assembly.
These pockets involve either one monomer (as pocket 2 along the linker domain), at the interface of two monomers (pocket 1 & 4), or at the six-fold interface (pocket 3).
Mutagenesis experiments revealed that core stability is fine-tuned to allow ordered disassembly during early stage of virus replication cycle [ref 4]. This is why selection of compounds will be done either for molecules which could stabilize or destabilize the hexamer; assuming that both actions could have impacts on the equilibrium of the core.
Our team from The Scripps Research Institute of San Diego, which includes Dr. Pierrick Craveur, Dr. Stefano Forli, and Prof. Arthur Olson, really appreciates the support this project receives from World Community Grid volunteers around the globe.
- Briggs, J. A. and H. G. Krausslich (2011). "The molecular architecture of HIV." J Mol Biol 410(4): 491-500.
- Thenin-Houssier, S. and S. T. Valente (2016). "HIV-1 Capsid Inhibitors as Antiretroviral Agents." Curr HIV Res 14(3): 270-282.
- Trott, O. and A. J. Olson (2010). "AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading." J Comput Chem 31(2): 455-461.
Forshey, B. M., U. von Schwedler, et al. (2002). "Formation of a human immunodeficiency virus type 1 core of optimal stability is crucial for viral replication." J Viro